ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

ADSTILADRIN (=INSTILADRIN) in Patients With High-Grade, Bacillus Calmette-Guerin (BCG) Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)

ClinicalTrials.gov ID: NCT02773849

Public ClinicalTrials.gov record NCT02773849. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 5:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Open Label Study to Evaluate the Safety and Efficacy of INSTILADRIN® (rAd-IFN)/Syn3) Administered Intravesically to Patients With High-Grade, BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)

Study identification

NCT ID
NCT02773849
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Ferring Pharmaceuticals
Industry
Enrollment
157 participants

Conditions and interventions

Interventions

  • ADSTILADRIN Biological

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 18, 2016
Primary completion
May 23, 2019
Completion
May 23, 2023
Last update posted
Jul 28, 2024

2016 – 2023

United States locations

U.S. sites
34
U.S. states
22
U.S. cities
32
Facility City State ZIP Site status
Banner MD Anderson Cancer Center Gilbert Arizona 85234
Keck School of Medicine at USC Medical Center Los Angeles California 90089
The Urology Center of Colorado Denver Colorado 80211
University of Florida - UF Health Davis Center Pavilion and Shands Med Plaza Gainesville Florida 32610
H. Lee Moffitt Cancer Center & Research Institute Tampa Florida 33612
Emory University School of Medicine Atlanta Georgia 30322
University of Chicago - Comprehensive Cancer Research Center Chicago Illinois 60637
Ochsner Clinic Foundation New Orleans Louisiana 70121
Johns Hopkins Kimmel Cancer Center Baltimore Maryland 21287
University of Michigan Ann Arbor Michigan 48109
Spectrum Health Medical Group Grand Rapids Michigan 49546
University of Minnesota Minneapolis Minnesota 55455
Mayo Clinic - Rochester Rochester Minnesota 55905
Washington University School of Medicine St Louis Missouri 63110
Delaware Valley Urology, LLC Voorhees Township New Jersey 08043
SUNY Upstate Medical Center Syracuse New York 13210
Montefiore Medical Center The Bronx New York 10461
University of North Carolina (UNC) - Chapel Hill Chapel Hill North Carolina 27599-7235
Duke University Durham North Carolina 27710
The University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104
Penn State Milton S. Hershey Medical Center Hershey Pennsylvania 17033
The Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104
Thomas Jefferson University Philadelphia Pennsylvania 19107
Regional Urology Greenville South Carolina 29605
Carolina Urologic research Center Myrtle Beach South Carolina 29572
Vanderbilt University Medical Center Dept. of Urologic Surgery Nashville Tennessee 37232
University of Texas Southwestern Medical Center Dallas Texas 75390
Baylor College of Medicine Houston Texas 77030
MD Anderson Cancer Center Houston Texas 77030
The Univ. of Texas Health Science Center at San Antonio San Antonio Texas 78229-3900
University of Virginia Health System Charlottesville Virginia 22908
Urology of Virginia Virginia Beach Virginia 23462
West Virginia University Cancer Institute Morgantown West Virginia 26506
University of Wisconsin - Madison Madison Wisconsin 53705

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02773849, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 28, 2024 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02773849 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →